Physician profile
Caroline Cho
NPI 1669552055
$3,315.24
in general payments reported to CMS, 2019-2025
13 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $52.97 · 2021: $337 · 2022: $1,470 · 2023: $810 · 2024: $305 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015 · Consulting Fee: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.26 |
| Consulting Fee | $260.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,682.14 | 2021-2024 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $532.54 | 2021-2022 | |
| Coopervision INC. | $405.42 | 2021-2025 | Paragon Crt, Ortho-K Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $235.08 | 2019-2025 | Total30 |
| Biotissue Holdings INC. | $146.76 | 2024-2025 | |
| Optos, INC. | $112.20 | 2021 | |
| Glaukos Corporation | $60.59 | 2022 | |
| Visioneering Technologies, INC. | $50.00 | 2019 | |
| Thea Pharma INC. | $21.95 | 2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Sight Sciences, INC. | $16.33 | 2020 | |
| Bausch & Lomb Americas INC. | $15.59 | 2025 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.